The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
Open accessAbstract
BACKGROUND: Higher circulating levels of the branched-chain amino acids (BCAAs; i.e., isoleucine, leucine, and valine) are strongly associated with higher type 2 diabetes risk, but it is not known whether this association is causal. We undertook large-scale human genetic analyses to address this question. METHODS AND FINDINGS: Genome-wide studies of BCAA levels in 16,596 individuals revealed five genomic regions associated at genome-wide levels of significance (p < 5 × 10-8). The strongest signal was 21 kb upstream of the PPM1K gene (beta in standard deviations [SDs] of leucine per allele = 0.08, p = 3.9 × 10-25), encoding an activator of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the rate-limiting step in BCAA catabolism. In another analysis, in up to 47,877 cases of type 2 diabetes and 267,694 controls, a genetically predicted difference of 1 SD in amino acid level was associated with an odds ratio for type 2 diabetes of 1.44 (95% CI 1.26-1.65, p = 9.5 × 10-8) for isoleucine, 1.85 (95% CI 1.41-2.42, p = 7.3 × 10-6) for leucine, and 1.54 (95% CI 1.28-1.84, p = 4.2 × 10-6) for valine. Estimates were highly consistent with those from prospective observational studies of the association between BCAA levels and incident type 2 diabetes in a meta-analysis of 1,992 cases and 4,319 non-cases. Metabolome-wide association analyses of BCAA-raising alleles revealed high specificity to the BCAA pathway and an accumulation of metabolites upstream of branched-chain alpha-ketoacid oxidation, consistent with reduced BCKD activity. Limitations of this study are that, while the association of genetic variants appeared highly specific, the possibility of pleiotropic associations cannot be entirely excluded. Similar to other complex phenotypes, genetic scores used in the study captured a limited proportion of the heritability in BCAA levels. Therefore, it is possible that only some of the mechanisms that increase BCAA levels or affect BCAA metabolism are implicated in type 2 diabetes. CONCLUSIONS: Evidence from this large-scale human genetic and metabolomic study is consistent with a causal role of BCAA metabolism in the aetiology of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, increased SCFA consumption may alleviate the hyperglycemic responses that are occurring in obese and type 2 diabetics, characterized by elevated amino-acid concentrations [154].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Self-citationDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
Self-citationGut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Cited by
Items 101–200 of 423
A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes
Liu, J., van Klinken, J. B., Semiz, S., van Dijk, K. W., Verhoeven, A., Hankemeier, T., Harms, A. C., Sijbrands, E. J. G., Sheehan, N. A., van Duijn, C. M., et al. (2017) · Diabetes · doi:10.2337/db17-0199 · Cited by 56
“The same method on twosample MR has been performed in the previous MR studies on type 2 diabetes (6,9,22).”
MethodMetabolomics of Diabetic Retinopathy
Liew, G., Zhou, L., Tan, G. S. W., Joachim, N., Ho, I., Wong, T. Y., Mitchell, P., Gopinath, B., & Crossett, B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0939-3 · Cited by 51
Metabolomic and genetic associations with insulin resistance in pregnancy
Liu, Y., Kuang, A., Talbot, O., Bain, J. R., Muehlbauer, M. J., Hayes, M. G., Ilkayeva, O., Lowe, L. P., Metzger, B. E., Newgard, C. B., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05198-1 · Cited by 55
“…in the non-gravid state is somewhat paradoxical in that the C allele of rs1260326 is associated with a greater risk of type 2 diabetes, higher levels of fasting glucose and insulin as well as insulin resistance, but lower levels of fasting triacylglycerols, alanine, leucine and isoleucine [42–44].”
Cheng, D., Zhao, X. Y., Yang, S., Cui, H., & Wang, G. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s294894 · Cited by 55
“A locus near PPMIK that was associated with BCAAs levels was correlated with the incidence of diabetes, suggesting that the BCAAs related genetic factors lead to diabetes.(43) Given that BCAAs have been extensively studied, BCAAs may be the most promising biomarker for distinguishing obesity phenotypes and may be a co…”
BackgroundIdentification of biomarkers for glycaemic deterioration in type 2 diabetes
Slieker, R. C., Donnelly, L. A., Akalestou, E., López–Noriega, L., Melhem, R., Güneş, A., Azar, F. A., Efanov, A. M., Georgiadou, E., Muniangi-Muhitu, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38148-7 · Cited by 57
Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study
Molnos, S., Wahl, S., Haid, M., Eekhoff, E. M. W., Pool, R., Floegel, A., Deelen, J., Much, D., Prehn, C. P., Breier, M., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4436-7 · Cited by 53
“A recent Mendelian randomisation study suggested that a causal relationship exists between increased BCAA levels and type 2 diabetes risk [36]; however, it remains to be shown that PC ae C32:2 or the ratio of valine to PC ae C32:2 are also causally related to the disease, but at present there are no genetic instrument…”
BackgroundSelf-citationWittenbecher, C., Guasch‐Ferré, M., Haslam, D. E., Dennis, C., Li, J., Bhupathiraju, S. N., Lee, C., Qi, Q., Liang, L., Eliassen, A. H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103799 · Cited by 53
Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults
Bragg, F., Kartsonaki, C., Yu, C., Holmes, M. V., Du, H., Yu, C., Pei, P., Yang, L., Jin, D., Chen, Y., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1415 · Cited by 48
Vasishta, S., Ganesh, K., Umakanth, S., & Joshi, M. B. (2022) · Metabolomics · doi:10.1007/s11306-022-01905-8 · Cited by 53
“The findings indicated improved glucose tolerance in European men whereas South Asian men did not respond to (PPM1K) gene which activates Branched Chain Amino Acid ketoacid dehydrogenase (BCKD) is associated with T2D (Lotta et al., 2016).”
BackgroundLee, J., Vijayakumar, A., White, P. J., Xu, Y., Ilkayeva, O., Lynch, C. J., Newgard, C. B., & Kahn, B. B. (2021) · Endocrinology · doi:10.1210/endocr/bqab062 · Cited by 52
Cord Blood Metabolomics: Association With Newborn Anthropometrics and C-Peptide Across Ancestries
Kadakia, R., Talbot, O., Kuang, A., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Ilkayeva, O., Lowe, L. P., Metzger, B. E., Newgard, C. B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00238 · Cited by 50
Kuo, F.-C., Neville, M. J., Sabaratnam, R., Wesolowska‐Andersen, A., Phillips, D., Wittemans, L. B. L., van Dam, A. D., Loh, N. Y., Todorčević, M., Denton, N., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111136 · Cited by 52
Self-citationNishi, K., Yoshii, A., Abell, L., Zhou, B., Frausto, R. F., Ritterhoff, J., McMillen, T. S., Sweet, I. R., Wang, Y., Gao, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112641 · Cited by 50
Cosentino, R. G., Churilla, J. R., Josephson, S., Molle‐Rios, Z., Hossain, J., do Prado, W. L., & Balagopal, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab538 · Cited by 52
Lin, H.-T., Cheng, M., Lo, C.-J., Lin, G., Lin, S., Yeh, J., Ho, H., Lin, J., & Liu, F.-C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060874 · Cited by 46
“A large-scale human genetic study using Mendelian randomization has verified the causal relationship for the elevation of plasma BCAAs levels and T2DM [33].”
Grenier–Larouche, T., Kwee, L. C., Deleye, Y., León‐Mimila, P., Walejko, J. M., McGarrah, R. W., Marceau, S., Trahan, S., Racine, C., Carpentier, A. C., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159204 · Cited by 49
Bishop, C. A., Machate, T., Henning, T., Henkel, J., Püschel, G. P., Weber, D., Grune, T., Klaus, S., & Weitkunat, K. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00200-8 · Cited by 47
“Increased circulating BCAA, deemed the “BCAA signature”, in obese and type-2-diabetic patients is a hallmark of disease [2–6], and impaired BCAA metabolism has been linked to a causal role in diabetes development [7].”
BackgroundSingh, S., Kriti, M., Anamika, K. S., Sarma, D. K., Verma, V., Nagpal, R., Mohania, D., Tiwari, R. R., & Kumar, M. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100287 · Cited by 61
“The BCAAs (isoleucine, leucine, and valine) and aromatic amino acids (phenylalanine and tyrosine) have consistently been identified as metabolite biomarkers for T2D [95].”
BackgroundMarkova, M., Hornemann, S., Sucher, S., Wegner, K., Pivovarova‐Ramich, O., Rudovich, N. N., Thomann, R., Schneeweiss, R., Rohn, S., & Pfeiffer, A. F. H. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy100 · Cited by 46
Omics and Cardiometabolic Disease Risk Prediction
Tahir, U. A., & Gerszten, R. E. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-042418-010924 · Cited by 47
The contradictory role of branched-chain amino acids in lifespan and insulin resistance
He, Y., Li, K., Wei, J., Lin, Y., & Liu, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1189982 · Cited by 47
Rizo‐Roca, D., Henderson, J. D., & Zierath, J. R. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20090 · Cited by 54
“A genome-wide study has highlighted the importance of the PPM1K gene in this process [14].”
Self-citationFlores-Guerrero, J. L., Gruppen, E. G., Connelly, M. A., SHALAUROVA, I. Y., Otvos, J. D., Garcia, E., Bakker, S. J. L., & Dullaart, R. P. F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092781 · Cited by 44
“Despite the fact that due to the design of our study we were not able to evaluate a causal mechanism, mendelian randomization studies have provided evidence about the causal relationship between BCAA and T2D [48].”
BackgroundKeijer, J., Escoté, X., Galmés, S., Palou-March, A., Serra, F. A., Aldubayan, M. A., Pigsborg, K., Magkos, F., Baker, E. J., Calder, P. C., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2198605 · Cited by 52
“The first polymorphism encodes a missense variant in the Glucokinase regulatory protein ( GCKR ) and this is associated with circulating levels of glucose (Shin et al. 2014), lactate (Tin et al. 2016) and BCAAs (valine, leucine and isoleucine) (Lotta et al. 2016).”
Ottosson, F. A., Smith, E., Gallo, W., Fernandez, C., & Melander, O. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00822 · Cited by 43
Melnik, B. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031059 · Cited by 46
BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice
Bollinger, E., Peloquin, M., Libera, J., Albuquerque, B., Pashos, E. E., Shipstone, A., Hadjipanayis, A. G., Sun, Z., Xing, G., Clasquin, M. F., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101611 · Cited by 47
Zeng, Y., Mtintsilana, A., Goedecke, J. H., Micklesfield, L. K., Olsson, T., & Chorell, E. (2019) · Metabolism · doi:10.1016/j.metabol.2019.04.001 · Cited by 46
Wang, Y., Huang, K., Liu, F., Lu, X., Huang, J., & Gu, D. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.04.026 · Cited by 45
Yuan, S., Merino, J., & Larsson, S. C. (2023) · Diabetologia · doi:10.1007/s00125-023-05879-7 · Cited by 47
“In an MR analysis using genetic variation at the PPM1K locus (which encodes a mitochondrial phosphatase that activates branchedchain α-ketoacid dehydrogenase [BCKD]), an increase in leucine, isoleucine and valine levels was associated with an increased odds of type 2 diabetes [50].”
BackgroundMethodWhole-body metabolic fate of branched-chain amino acids
Blair, M. C., Neinast, M. D., & Arany, Z. P. (2021) · Biochemical Journal · doi:10.1042/bcj20200686 · Cited by 40
Sjögren, R. J. O., Rizo‐Roca, D., Chibalin, A., Chorell, E., Furrer, R., Katayama, S., Harada, J., Karlsson, H., Handschin, C., Möritz, T., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05481-9 · Cited by 43
Self-citationZhou, C., Zhang, Q., Lu, L., Wang, J., Liu, D., & Liu, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.765873 · Cited by 43
Dehghan, A., Pinto, R. C., Karaman, İ., Huang, J. V., Durainayagam, B. R., Ghanbari, M., Nazeer, A., Zhong, Q., Liggi, S., Whiley, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206083119 · Cited by 38
Self-citationGoñi, L., Qi, L., Cuervo, M., Milagro, F. I., Saris, W. H. M., Macdonald, I. A., Langin, D., Astrup, A. V., Arner, P., Oppert, J., et al. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156281 · Cited by 46
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Mann, J. P., Pietzner, M., Wittemans, L. B. L., Rolfe, E. D. L., Kerrison, N. D., Imamura, F., Forouhi, N. G., Fauman, E. B., Allison, M., Griffin, J. L., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa162 · Cited by 43
“NAFLDassociated genotypes were assessed for associations with anthropometric and metabolic traits using linear regression (coding effect allele dosage as 0, 1 and 2) adjusting for age, sex and the first ten principal components from a principal component analyses on the genetic data to account for population stratific…”
MethodSelf-citationMetabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
Izundegui, D. G., & Nayor, M. G. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01449-0 · Cited by 39
Seah, J. Y. H., Hong, Y., Cichońska, A., Sabanayagam, C., Nusinovici, S., Wong, T. Y., Cheng, C., Jousilahti, P., Lundqvist, A., Perola, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac212 · Cited by 46
Flach, R. J. R., Bollinger, E., Reyes, A. R., Laforest, B., Kormos, B. L., Liu, S., Reese, M. R., Martinez-Alsina, L., Buzon, L. M., Zhang, Y. E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40536-y · Cited by 45
“TheBCAAcatabolicpathwayisdysfunctionalinamultitudeofdiseases including metabolic syndrome 2,16,31,32 , HF 11,33 , NAFLD 34,35 , cancer 36 , and aging 1,2,10,11,29,36 – 40 .”
Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes
Hart, L. M. ‘., Vogelzangs, N., Mook-Kanamori, D. O., Brahimaj, A., Nano, J., van der Heijden, A. A. W. A., van Dijk, K. W., Slieker, R. C., Steyerberg, E. W., Ikram, M. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01165 · Cited by 37
“The BCAAs, although shown to be causally related to development of T2D (21), were not associated with the progression to insulin use.”
BackgroundInfluentialCirculating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
Adams, C. D., Richmond, R. C., Ferreira, D. L. S., Spiller, W., Tan, V. Y., Zheng, J., Würtz, P., Donovan, J., Hamdy, F. C., Neal, D. E., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0079 · Cited by 39
Self-citationSerum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
Gunther, S. H., Khoo, C. M., Tai, E. S., Sim, X., Kovalik, J., Ching, J., Lee, J. J., & van Dam, R. M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001315 · Cited by 44
Metabolomics applied to diabetes−lessons from human population studies
Liggi, S., & Griffin, J. L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.011 · Cited by 39
Self-citationPorcu, E., Gilardi, F., Darrous, L., Yengo, L., Bararpour, N., Gasser, M., Marques-Vidal, P. M., Froguel, P., Waeber, G., Thomas, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85684-7 · Cited by 35
Luo, K., Chen, G., Zhang, Y., Moon, J., Xing, J., Peters, B. A., Usyk, M., Wang, Z., Hu, G., Li, J., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00961-1 · Cited by 41
Bell, J. A., Bull, C. J., Gunter, M. J., Carslake, D., Mahajan, A., Smith, G. D., Timpson, N. J., & Vincent, E. E. (2020) · Diabetes Care · doi:10.2337/dc19-2348 · Cited by 35
“lead to inflatedMRestimates via a “doublecounting” of allele effects, as was likely the case previously (35,37) where the variant rs1440581 was used to instrument both leucine and valine.”
MethodThe “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease
Silva, L. F., Vangipurapu, J., & Laakso, M. (2021) · Metabolites · doi:10.3390/metabo11100691 · Cited by 38
“Their study provided genetic evidence that insulin resistance has a causal role on branched chain amino acids, in contrast to a previous study [97].”
BackgroundResultGamma-glutamyl-leucine levels are causally associated with elevated cardio-metabolic risks
Wu, Q. H., Li, J., Zhu, J., Sun, X., He, D., Li, J., Cheng, Z., Zhang, X., Xu, Y., Chen, Q., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.936220 · Cited by 34
Saleem, T. H., Dahpy, M. A., Ezzat, G. M., Abdelrahman, G., Abdel-Aziz, E. M., & Farghaly, R. (2019) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-019-02956-9 · Cited by 41
Liao, X., Liu, B., Qu, H., Zhang, L., Lu, Y., Xu, Y., Lyu, Z., & Zheng, H. (2019) · Mediators of Inflammation · doi:10.1155/2019/8247019 · Cited by 38
“A prospective observational study reported that the elevation of BCAAs is associated with the risk of T2D [12, 34], and recent genetic studies have suggested the important role of BCAA metabolism in the development of diabetes [35].”
BackgroundBranched-Chain Amino Acids and Risk of Breast Cancer
Zeleznik, O. A., Balasubramanian, R., Ren, Y., Tobias, D. K., ROSNER, B. A., Peng, C., Bever, A. M., Frueh, L., Jeanfavre, S., Ávila-Pacheco, J., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab059 · Cited by 38
Mietus‐Snyder, M., Perak, A. M., Cheng, S. C., Hayman, L. L., Haynes, N., Meikle, P. J., Shah, S. H., & Suglia, S. F. (2023) · Circulation · doi:10.1161/cir.0000000000001185 · Cited by 35
Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health
Li, C., Cheng, D., Ren, H., & Zhang, T. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529703 · Cited by 48
Ke, X., Li, K., Jiang, A., Zhang, Y., Wang, Q., Li, Z., Zhang, J., Hajd, A., Shi, W., Kahlert, U. D., et al. (2025) · Med Research · doi:10.1002/mdr2.70040 · Cited by 32
Cord Blood Metabolites Associated with Newborn Adiposity and Hyperinsulinemia
Kadakia, R., Scholtens, D. M., Rouleau, G. W., Talbot, O., Ilkayeva, O., George, T., & Josefson, J. L. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.07.056 · Cited by 35
Lim, L., Lau, E. S. H., Fung, E., Lee, H. M., Ronald, C. W., Tam, C. H. T., Wong, W. K. K., Ng, A. C. W., Chow, E., Luk, A. O. Y., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3253 · Cited by 45
“In a Mendelian randomization study involving individuals of European ancestry, variants at the PPM1K gene that encode the mitochondrial phosphatase 2c (PP2Cm) necessary for BCKDH activation were strongly associated with increased circulating levels of BCAAs and risk of T2D.2 However, the weighted genetic risk score on…”
BackgroundInfluentialRoberts, J. A., Varma, V. R., Huang, C.-W., An, Y., Oommen, A. M., Tanaka, T., Ferrucci, L., Elango, P., Takebayashi, T., Harada, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041249 · Cited by 40
Endotoxemia is associated with an adverse metabolic profile
Määttä, A.-M., Salminen, A., Pietiäinen, M., Leskelä, J., Palviainen, T., Sattler, W., Sinisalo, J. P., Salomaa, V. V., Kaprio, J. A., & Pussinen, P. J. (2020) · Innate Immunity · doi:10.1177/1753425920971702 · Cited by 35
“The branched-chain Aas were previously shown to be associated with insulin resistance and diabetes risk.(31,32) Mechanistically it was suggested that branched-chain Aas together with lipoprotein-derived lipids affect the responsiveness of peripheral tissues to insulin, as branched-chain Aa-induced insulin resistance i…”
BackgroundAberrant branched-chain amino acid catabolism in cardiovascular diseases
Xiong, Y., Jiang, L., & Li, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.965899 · Cited by 32
Lovestone, S. (2019) · Learning Health Systems · doi:10.1002/lrh2.10214 · Cited by 32
Strawbridge, R. J., & van Zuydam, N. R. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1021-5 · Cited by 36
Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance
Wildberg, C., Masuch, A., Budde, K., Kastenmüller, G., Artati, A., Rathmann, W., Adamski, J., Kocher, T., Völzke, H., Nauck, M. A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01104 · Cited by 31
Gao, J., Mao, K., Wang, X., Mi, S., Fu, M., Li, X., Xiao, J., Simal‐Gándara, J., & Sang, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02430 · Cited by 32
Zhao, J., Stewart, I. D., Baird, D. A., Mason, D., Wright, J., Zheng, J., Gaunt, T. R., Evans, D. M., Freathy, R. M., Langenberg, C., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104441 · Cited by 28
Self-citationAmino acid profile in women with gestational diabetes mellitus treated with metformin or insulin
Huhtala, M. S., Tertti, K., Pellonperä, O., & Rönnemaa, T. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.014 · Cited by 33
Shahisavandi, M., Wang, K., Ghanbari, M., & Ahmadizar, F. (2023) · Genes · doi:10.3390/genes14071464 · Cited by 35
Branched-chain amino acids are associated with metabolic parameters in bipolar disorder
Fellendorf, F. T., Platzer, M., Pilz, R., Rieger, A., Kapfhammer, H., Mangge, H., Dalkner, N., Zelzer, S., Meinitzer, A., Birner, A., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1487077 · Cited by 31
Bozadjieva-Kramer, N., Evers, S. S., Shin, J. H., Silverwood, S., Wang, Y., Burant, C., Sandoval, D. A., & Seeley, R. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108239 · Cited by 32
“Importantly, these data have led to the hypothesis that increased BCAA levels directly contribute to metabolic dysfunction in patients with obesity and T2D.”
BackgroundInfluentialAmino Acid-Induced Impairment of Insulin Signaling and Involvement of G-Protein Coupling Receptor
Zakaria, N., Hamid, M., & Khayat, M. E. (2021) · Nutrients · doi:10.3390/nu13072229 · Cited by 38
“PMK1 was upregulated in normoglycemic subjects and vice versa [64].”
BackgroundAdiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study
Pang, Y., Kartsonaki, C., Lv, J., Millwood, I. Y., Fairhurst-Hunter, Z., Turnbull, I. J., Bragg, F., Hill, M., Yu, C., Guo, Y., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab392 · Cited by 32
“Although previous studies suggested genetic associations of BCAAs with insulin resistance and diabetes (52, 53), there is limited evidence on the genetic associations between metabolomic biomarkers with NAFLD.”
A systematic review of metabolomics biomarkers for Bisphenol A exposure
Wang, M., Rang, O., Liu, F., Xia, W., Li, Y., Zhang, Y., Lu, S., & Xu, S. (2018) · Metabolomics · doi:10.1007/s11306-018-1342-z · Cited by 28
Li, H., & Seugnet, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02020 · Cited by 30
Tănase, D. M., Valasciuc, E., Costea, C. F., Scripcariu, D. V., Ouatu, A., Hurjui, L. L., Tărniceriu, C. C., Floria, D., Ciocoiu, M., Baroi, L. G., et al. (2024) · Nutrients · doi:10.3390/nu16121972 · Cited by 28
“…BCAA levels associated with insulin resistance and T2D [75] Genome-wide study of 16,596 patients BCAA levels associated with a higher risk of T2D [76] Case–control study of 2422 patients in the Framingham cohort BCAA levels associated with a higher risk of T2D [77] Cohort of 1279 European and…”
BackgroundHaydar, S., Grigorescu, F., Vintilă, M., Cogne, Y., Lautier, C., Tütüncü, Y., Brun, J. ‐., Robine, J., PUGEAT, M. M., Normand, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214122 · Cited by 26
“Therefore, we cannot exclude the possibility that our collection of MetS contains subjects with IR different from T2D as in previous GWAS.”
BackgroundResultInfluentialHsu, Y.-H. H., Astley, C. M., Cole, J. B., Vedantam, S., Mercader, J. M., Metspalu, A., Fischer, K., Fortney, K., Morgen, E. K., González, C., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0603-x · Cited by 28
“This locus has been linked with all three BCAAs, including valine, in previous studies [31, 41].”
ResultGawędzka, A., Grandys, M., Duda, K., Zapart-Bukowska, J., Zoladz, J. A., & Majerczak, J. (2020) · PeerJ · doi:10.7717/peerj.10491 · Cited by 30
“This results support the suggested relation between higher plasma BCAA concentration with a decreased insulin sensitivity (Lotta et al., 2016;Wang et al., 2011).”
BackgroundResultTrub, C. J., Balikcioglu, M., Freemark, M., Bain, J. R., Muehlbauer, M. J., Ilkayeva, O., White, P. J., Armstrong, S., Østbye, T., Grambow, S. C., et al. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.250 · Cited by 30
Regulation of cold-induced thermogenesis by the RNA binding protein FAM195A
Cannavino, J., Shao, M., An, Y., Bezprozvannaya, S., Chen, S., Kim, J., Xu, L., McAnally, J., Scherer, P. E., Liu, N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104650118 · Cited by 33
Doestzada, M., Zhernakova, D. V., van den Munckhof, I., Wang, D., Kurilshikov, A., Chen, L., Bloks, V. W., van Faassen, M. H. J. R., Rutten, J. H. W., Joosten, L. A. B., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02688-4 · Cited by 28
“reported that changes in BCAA levels contribute to IR and the incidence of type 2 diabetes [45], whereas more recent studies showed evidence of a BCAA effect on IR [46, 47].”
ResultA Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction
Merino, J., Udler, M. S., Leong, A., & Meigs, J. B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0958-0 · Cited by 35
Fan, J., Wang, X., Xiao, R., & Li, M. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009080 · Cited by 26
“Cell type compositions and selected genes with cell-type-specific AEI associated with the progression of T2D of the Fadiata pancreatic islets RNA-seq data.”
BackgroundInfluentialHudd, F., Shiel, A., Harris, M., Bowdler, P., McCann, B., Tsivos, D., Wearn, A., Knight, M., Kauppinen, R., Coulthard, E., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180879 · Cited by 26
Zhang, X., Ojanen, X., Zhuang, H., Wu, N., Cheng, S., & Wiklund, P. (2019) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2019.01.030 · Cited by 27
Wu, J., Zhao, M., Li, C., Zhang, Y., & Wang, D. W. (2021) · Bioscience Reports · doi:10.1042/bsr20204201 · Cited by 26
Balikcioglu, P. G., Trub, C. J., Balikcioglu, M., Ilkayeva, O., White, P. J., Muehlbauer, M. J., Bain, J. R., Armstrong, S., & Freemark, M. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.388 · Cited by 29
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study
Sharma, S., Dong, Q., Haid, M., Adam, J., Bizzotto, R., Fernandez-Tajes, J. J., Jones, A. G., Tura, A., Artati, A., Prehn, C. P., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06282-6 · Cited by 26
Self-citationBragg, F., Kartsonaki, C., Yu, C., Holmes, M. V., Du, H., Yu, C., Pei, P., Yang, L., Jin, D., Chen, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19159-8 · Cited by 25
Branched-Chain Amino Acids Metabolism and Their Roles in Retinopathy: From Relevance to Mechanism
Zhang, X., Xia, M., Wu, Y., & Zhang, F. (2023) · Nutrients · doi:10.3390/nu15092161 · Cited by 30
“Vitreous samples were collected from twentyeight patients of type 2 diabetes (T2D) with PDR and twenty-two non-diabetic patients with macular hole.”
BackgroundInfluentialZhang, Y., Zhou, Q., Yang, R., Hu, C., Huang, Z., Zheng, C., Liang, Q., Gong, R., Zhu, X., Gong, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67010-9 · Cited by 27
Goldberg, E. J., Buddo, K. A., McLaughlin, K., Fernandez, R. F., Pereyra, A. S., Psaltis, C. E., Lin, C., Hagen, J. T., Boykov, I. N., Nguyen, T. K., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190182 · Cited by 24
Bos, M. M., Goulding, N., Lee, M. A., Hofman, A., Bot, M., Pool, R., Vijfhuizen, L. S., Zhang, X., Li, C., Mustafa, R., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01939-0 · Cited by 22
Ouyang, Y., Qiu, G., Zhao, X., Su, B., Feng, D., Lv, W., Xuan, Q., Wang, L., Yu, D., Wang, Q., et al. (2021) · Global Challenges · doi:10.1002/gch2.202000088 · Cited by 28
Aon, M. A., Cortassa, S. C., Juhaszova, M., González-Reyes, J. A., Calvo‐Rubio, M., Villalba, J. M., Lachance, A. D., Ziman, B. D., Mitchell, S. J., Murt, K. N., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-020-00054-3 · Cited by 25
Zhou, X., Zhang, J., Shen, J., Cheng, B., Bi, C., & Ma, Q. (2023) · Food & Function · doi:10.1039/d3fo03899h · Cited by 24
Yazdani, A., Yazdani, A., Elsea, S. H., Schaid, D. J., Kosorok, M. R., Dangol, G., & Samiei, A. (2019) · BMC Genomics · doi:10.1186/s12864-019-5772-4 · Cited by 26
“Studies have shown that higher levels of leucine or isoleucine are strongly related to insulin resistance, obesity, and higher risk of type 2 diabetes (35, 36).”
BackgroundLind, L., Salihović, S., Risérus, U., Kullberg, J., Johansson, L., Ahlström, H. K., Eriksson, J. W., & Oscarsson, J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa693 · Cited by 27
Liang, Y., Luo, S., Wong, T. H. T., He, B., Schooling, C. M., & Yeung, S. L. A. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad093 · Cited by 23
Defective branched‐chain amino acid catabolism in dorsal root ganglia contributes to mechanical pain
Xie, H., Li, J., Lian, N., Xie, M., Wu, M., Tang, K., Kang, Y., Lu, P., & Li, T. (2023) · EMBO Reports · doi:10.15252/embr.202356958 · Cited by 22
“Maple syrup urine disease, an autosomal recessive disorder caused by decreased activity of BCKDH, is featured by neurological disorders and elevated brain lactate (Xu et al , 2020a).”
InfluentialMyobolites: muscle-derived metabolites with paracrine and systemic effects
Ibrahim, A., Neinast, M., & Arany, Z. P. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.03.007 · Cited by 22
Mantha, O. L., Polakof, S., Huneau, J., Mariotti, F., Poupin, N., Zalko, D., & Fouillet, H. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518000326 · Cited by 24
“However, the causes and underlying mechanisms are still poorly understood, and this is because of several reasons((17,18)).”
Background
Metadata
- Authors
- Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., Marney, L., Koulman, A., Karoly, E. D., Forouhi, N. G., Sjögren, R. J. O., Näslund, E., Zierath, J. R., Krook, A., Savage, D. B., Griffin, J. L., Chaturvedi, N., Hingorani, A. D., Khaw, K.-T., Barroso, I., McCarthy, M. I., O’Rahilly, S., Wareham, N. J., & Langenberg, C.
- Affiliations
- University of Cambridge (GB)
- University College London (GB)
- MRC Elsie Widdowson Laboratory (GB)
- Metabolon (United States) (US)
- Karolinska Institutet (SE)
- Danderyds sjukhus (SE)
- Centre for Human Genetics (GB)
- Corresponding author
- Wareham, Nicholas J.
- Langenberg, Claudia
- ORCID
- Lotta, Luca A.
- Scott, Robert A.
- Sharp, Stephen J.
- Burgess, Stephen
- Luan, Jian’an
- Tillin, Therese
- Schmidt, Amand F.
- Imamura, Fumiaki
- Perry, John R. B.
- Marney, Luke
- Koulman, Albert
- Karoly, Edward D.
- Forouhi, Nita G.
- Sjögren, Rasmus J. O.
- Näslund, Erik
- Zierath, Juleen R.
- Krook, Anna
- Savage, David B.
- Griffin, Julian L.
- Chaturvedi, Nishi
- Hingorani, Aroon D.
- Khaw, Kay-Tee
- Barroso, Inês
- McCarthy, Mark I.
- O’Rahilly, Stephen
- Wareham, Nicholas J.
- Langenberg, Claudia
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-29
- Volume
- 13
- Issue
- 11
- Pages
- e1002179
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5127513
- OpenAlex
- W2559236589
- Cited by
- 417
- References
- 73
- Citations by year
- 2026: 20 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 49 · 2021: 61 · 2020: 50 · 2019: 31 · 2018: 52 · 2017: 21 · 2016: 1
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_12015/1, MC_PC_13046, MC_PC_13048 and MR/L00002/1 - MRC Epidemiology Unit, MC_UP_A090_1006 - MRC Human Nutrition Research, SABRE Study)
- National Institute for Health Research (Biomedical Research Centre—MRC Epidemiology Unit)
- EMIF (n° 115372)
- Cambridge Lipidomics Biomarker Research Initiative (G0800783 - MRC Epidemiology Unit and MRC Human Nutrition Research)
- Diabetes UK (SABRE Study)
- British Heart Foundation (GB) (SABRE Study)
- Wellcome Trust (GB) (WT082464 - SABRE Study, SP/07/001/23603 - SABRE Study)
- Diabetes UK (GB) (13/0004774 - SABRE Study)
- Vetenskapsrådet (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Novo Nordisk Foundation (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Diabetes Wellness (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Wellcome Trust (107064, 090532, 098381, WT098051)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- branched-chain amino acids, type 2 diabetes, branched-chain amino acid metabolism, PPM1K, branched-chain ketoacid dehydrogenase, genetic susceptibility, causal inference, isoleucine, leucine, valine, circulating amino acids, polygenic risk score, heritability, pleiotropy, mitochondrial metabolism, metabolite accumulation
- MeSH terms
- Adult, Aged, Amino Acids, Branched-Chain, Diabetes Mellitus, Type 2, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Sweden, Genetic Predisposition to Disease, Genome-Wide Association Study, Young Adult, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.